InterCure Ltd. (NASDAQ:INCR) Sees Large Growth in Short Interest

InterCure Ltd. (NASDAQ:INCR) was the recipient of a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 37,200 shares, an increase of 129.6% from the November 15th total of 16,200 shares. Approximately 0.1% of the company’s shares are sold short. Based on an average daily trading volume, of 32,400 shares, the short-interest ratio is currently 1.1 days.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Renaissance Technologies LLC increased its holdings in shares of InterCure by 30.9% in the second quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock worth $91,000 after buying an additional 10,700 shares during the period. AdvisorShares Investments LLC purchased a new position in InterCure during the 2nd quarter valued at about $218,000. Jane Street Group LLC purchased a new position in InterCure during the 3rd quarter valued at about $49,000. Finally, Virtu Financial LLC purchased a new position in InterCure during the 3rd quarter valued at about $43,000. Hedge funds and other institutional investors own 8.34% of the company’s stock.

InterCure Trading Down 1.5 %

INCR opened at $1.32 on Friday. The business’s 50-day moving average price is $1.55 and its 200-day moving average price is $1.96. The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15. InterCure has a 12 month low of $1.17 and a 12 month high of $3.72.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.